Clinical trial
Combination Chemotherapy Before Surgery in Treating Women With Breast Cancer
NCT00008034 · European Organisation for Research and Treatment of Cancer - EORTC, Other · Completed
Key facts
| NCT number | NCT00008034 |
|---|---|
| Title | Combination Chemotherapy Before Surgery in Treating Women With Breast Cancer |
| Official title | A Phase I Study Of Cyclophoshamide And Epirubicin In Combination With Capecitabine (XELODA) (CEX) As Primary Treatment Of Locally Advanced/Inflammatory Or Large Operable Breast Cancer |
| Lead sponsor | European Organisation for Research and Treatment of Cancer - EORTC, Other |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug |
| Interventions | capecitabine, cyclophosphamide, epirubicin hydrochloride |
| Enrollment | 15 |
| Start date | Feb 1, 2000 |
| Primary completion | Dec 1, 2000 |
| First posted | Feb 3, 2004 |
| Last update posted | Jul 18, 2012 |
| Countries | Switzerland |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: